End-of-day quote
Other stock markets
|
||
- USD | - |
Mar. 26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 14.8M | Sales 2025 * | 19.28M | Capitalization | 2.78M |
---|---|---|---|---|---|
Net income 2024 * | -3M | Net income 2025 * | - | EV / Sales 2024 * | 0.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
3.08
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on NovaBay Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Justin Hall
CEO | Chief Executive Officer | 46 | 13-01-31 |
Tommy Law
DFI | Director of Finance/CFO | 38 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Freiman
CHM | Chairman | 89 | 02-04-30 |
Yen You Zheng
BRD | Director/Board Member | 67 | 19-09-10 |
Bob Wu
BRD | Director/Board Member | 49 | 16-01-25 |